A closely cropped shot of two women with their arms intertwined



Innovate UK logo

嘉乐丽临床护理及其母公司得到了英国政府创新机构 Innovate UK 的慷慨支持。
2021 年 11 月,该机构确认授予本公司额外的经费,以推进研发工作

University Hospitals Coventry & Warwickshire

CLCC has designed an in-woman trial of our device with progesterone, working closely with the Clinical Trials Unit from University Hospitals Coventry & Warwickshire (UHCW). This is led by Professor Siobhan Quenby, our clinical co-lead and one of the world’s foremost authorities on miscarriage and preterm birth prevention. Siobhan led the highly-cited Lancet series (2021) on miscarriage and was co-applicant, major recruiter to and co-author on the two largest and most significant trials of vaginal progesterone to prevent miscarriage (PROMISE and PRISM). The results of these trials led to the UK’s NICE updating its miscarriage guideline, to now recommend women at high risk of miscarriage to take vaginal progesterone twice daily for up to 80 days – guidance that has subsequently been adopted in Australia and we believe is being closely followed in other countries, with potential to further expand the market opportunity for this indication

欲了解更多有关合作伙伴关系,或其他商业发展机会的信息,请电邮至 info@callali.ly或致电 +44 (0) 20 7754 5400